世界のヘリコバクターピロリ診断市場2020-2024

◆英語タイトル:Global Helicobacter Pylori Diagnostics Market 2020-2024
◆商品コード:IRTNTR41646
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年4月30日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートではヘリコバクターピロリ診断の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、技術別(免疫測定、分子診断、POC)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・ヘリコバクターピロリ診断の世界市場:技術別(免疫測定、分子診断、POC)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Helicobacter Pylori Diagnostics Market 2020-2024

Technavio has been monitoring the helicobacter pylori diagnostics market and it is poised to grow by $ 209.59 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on helicobacter pylori diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing cost-effectiveness of diagnosis in conjunction with personalized antibiotic therapy and resistance of H. pylori to antibiotics. In addition, growing cost-effectiveness of diagnosis in conjunction with personalized antibiotic therapy is anticipated to boost the growth of the market as well.

The helicobacter pylori diagnostics market analysis includes technology segment and geographic landscapes
Technavio’s helicobacter pylori diagnostics market is segmented as below:
By Technology
• Immunoassays
• Molecular diagnostics
• POC

By Geographic Landscapes
• North America
• Europe
• APAC

This study identifies the rising prevalence of disease as one of the prime reasons driving the helicobacter pylori diagnostics market growth during the next few years.
“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our helicobacter pylori diagnostics market covers the following areas:
• Helicobacter pylori diagnostics market sizing
• Helicobacter pylori diagnostics market forecast
• Helicobacter pylori diagnostics market industry analysis”

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading helicobacter pylori diagnostics market vendors that include Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Omega Diagnostics Group Plc, QIAGEN N.V., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.. Also, the helicobacter pylori diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-helicobacter-pylori-diagnostics-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Technology
o Market segments
o Comparison by Technology
o Immunoassays – Market size and forecast 2019-2024
o Molecular diagnostics – Market size and forecast 2019-2024
o POC – Market size and forecast 2019-2024
o Market opportunity by Technology
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume driver – Demand led growth
o Volume driver – External factors
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o bioMérieux SA
o Bio-Rad Laboratories Inc.
o Cardinal Health Inc.
o F. Hoffmann-La Roche Ltd.
o Omega Diagnostics Group Plc
o QIAGEN N.V.
o Quest Diagnostics Inc.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1.Key Finding 1
• 2.Key Finding 2
• 3.Key Finding 3
• 4.Key Finding 5
• 5.Key Finding 6
• 6.Key Finding 7
• 7.Key Finding 8
• 8.Market in focus
• 9.Parent market
• 10.Market characteristics
• 11.Offerings of vendors included in the market definition
• 12.Market segments
• 13.Global – Market size and forecast 2019 – 2024 ($ million)
• 14.Global market: Year-over-year growth 2019 – 2024 (%)
• 15.Five forces analysis 2019 & 2024
• 16.Bargaining power of buyers
• 17.Bargaining power of suppliers
• 18.Threat of new entrants
• 19.Threat of substitutes
• 20.Threat of rivalry
• 21.Market condition – Five forces 2019
• 22.Technology placement – Market share 2019-2024 (%)
• 23.Comparison by Technology
• 24.Immunoassays – Market size and forecast 2019-2024 ($ million)
• 25.Immunoassays – Year-over-year growth 2019-2024 (%)
• 26.Molecular diagnostics – Market size and forecast 2019-2024 ($ million)
• 27.Molecular diagnostics – Year-over-year growth 2019-2024 (%)
• 28.POC – Market size and forecast 2019-2024 ($ million)
• 29.POC – Year-over-year growth 2019-2024 (%)
• 30.Market opportunity by Technology
• 31.Customer landscape
• 32.Market share by geography 2019-2024 (%)
• 33.Geographic comparison
• 34.North America – Market size and forecast 2019-2024 ($ million)
• 35.North America – Year-over-year growth 2019-2024 (%)
• 36.Europe – Market size and forecast 2019-2024 ($ million)
• 37.Europe – Year-over-year growth 2019-2024 (%)
• 38.APAC – Market size and forecast 2019-2024 ($ million)
• 39.APAC – Year-over-year growth 2019-2024 (%)
• 40.ROW – Market size and forecast 2019-2024 ($ million)
• 41.ROW – Year-over-year growth 2019-2024 (%)
• 42.Key leading countries
• 43.Market opportunity by geography ($ million)
• 44.Impact of drivers and challenges
• 45.Vendor landscape
• 46.Landscape disruption
• 47.Industry risks
• 48.Vendors covered
• 49.Market positioning of vendors
• 50.Abbott Laboratories – Overview
• 51.Abbott Laboratories – Business segments
• 52.Abbott Laboratories – Key offerings
• 53.Abbott Laboratories – Key customers
• 54.Abbott Laboratories – Segment focus
• 55.Becton, Dickinson and Co. – Overview
• 56.Becton, Dickinson and Co. – Business segments
• 57.Becton, Dickinson and Co. – Key offerings
• 58.Becton, Dickinson and Co. – Key customers
• 59.Becton, Dickinson and Co. – Segment focus
• 60.bioMérieux SA – Overview
• 61.bioMérieux SA – Business segments
• 62.bioMérieux SA – Key offerings
• 63.bioMérieux SA – Key customers
• 64.bioMérieux SA – Segment focus
• 65.Bio-Rad Laboratories Inc. – Overview
• 66.Bio-Rad Laboratories Inc. – Business segments
• 67.Bio-Rad Laboratories Inc. – Key offerings
• 68.Bio-Rad Laboratories Inc. – Key customers
• 69.Bio-Rad Laboratories Inc. – Segment focus
• 70.Cardinal Health Inc. – Overview
• 71.Cardinal Health Inc. – Business segments
• 72.Cardinal Health Inc. – Key offerings
• 73.Cardinal Health Inc. – Key customers
• 74.Cardinal Health Inc. – Segment focus
• 75.F. Hoffmann-La Roche Ltd. – Overview
• 76.F. Hoffmann-La Roche Ltd. – Business segments
• 77.F. Hoffmann-La Roche Ltd. – Key offerings
• 78.F. Hoffmann-La Roche Ltd. – Key customers
• 79.F. Hoffmann-La Roche Ltd. – Segment focus
• 80.Omega Diagnostics Group Plc – Overview
• 81.Omega Diagnostics Group Plc – Business segments
• 82.Omega Diagnostics Group Plc – Key offerings
• 83.Omega Diagnostics Group Plc – Key customers
• 84.Omega Diagnostics Group Plc – Segment focus
• 85.QIAGEN N.V. – Overview
• 86.QIAGEN N.V. – Business segments
• 87.QIAGEN N.V. – Key offerings
• 88.QIAGEN N.V. – Key customers
• 89.QIAGEN N.V. – Segment focus
• 90.Quest Diagnostics Inc. – Overview
• 91.Quest Diagnostics Inc. – Business segments
• 92.Quest Diagnostics Inc. – Key offerings
• 93.Quest Diagnostics Inc. – Key customers
• 94.Quest Diagnostics Inc. – Segment focus
• 95.Thermo Fisher Scientific Inc. – Overview
• 96.Thermo Fisher Scientific Inc. – Business segments
• 97.Thermo Fisher Scientific Inc. – Key offerings
• 98.Thermo Fisher Scientific Inc. – Key customers
• 99.Thermo Fisher Scientific Inc. – Segment focus
• 100.Currency conversion rates for US$
• 101.Research Methodology
• 102.Validation techniques employed for market sizing
• 103.Information sources
• 104.List of abbreviations



【掲載企業】

Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Omega Diagnostics Group Plc, QIAGEN N.V., Quest Diagnostics Inc., Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のヘリコバクターピロリ診断市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆